* Biosig Technologies Inc BSGM.OQ reported a quarterly
adjusted loss of 26 cents per share for the quarter ended
in March. The lone analyst forecast for the quarter was for a
loss of 15 cents per share.
* Revenue was $118.00 thousand; analysts expected $921.00
thousand.
* Biosig Technologies Inc's reported EPS for the quarter was a
loss of 26 cents.
* The mean earnings estimate of analysts had risen by
about 16.7% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Biosig Technologies Inc shares had fallen by 22.7% this
quarter and lost 14.6% so far this year.
* The company reported a quarterly loss of $8.32 million.
* Wall Street's median 12-month price target for Biosig
Technologies Inc is $13.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 17 at 11:18 p.m. GMT.
All figures in US dollars